Publications
Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R. TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. Radiology. 2016. PMID: 26744927
Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ, Belch A, Krishnan A, Vescio RA, Mateos MV, Mazumder A, Orlowski RZ, Sutherland HJ, Bladé J, Scott EC, Oriol A, Berdeja J, Gharibo M, Stevens DA, LeBlanc R, Sebag M, Callander N, Jakubowiak A, White D, de la Rubia J, Richardson PG, Lisby S, Feng H, Uhlar CM, Khan I, Ahmadi T, Voorhees PM. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet (London, England). 2016. PMID: 26778538
Brondfield S, Feingold KR. Symptomatic Graves' Disease After Autoimmune Hypothyroidism. The American journal of medicine. 2016. PMID: 26772649
Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leukemia & lymphoma. 2016. PMID: 26490487
Ikuta T, Sellak H, Odo N, Adekile AD, Gaensler KM. Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis. PloS one. 2016. PMID: 26727002
Majd N, Wei X, Demopoulos A, Hormigo A, Chari A. Characterization of central nervous system multiple myeloma in the era of novel therapies. Leukemia & lymphoma. 2016. PMID: 26727654
Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA oncology. 2016. PMID: 26539793
Okimoto RA, Bivona TG. Tracking Down Response and Resistance to TRK Inhibitors. Cancer discovery. 2016. PMID: 26747892
Rugo HS, Vidula N, Ma C. Improving Response to Hormone Therapy in Breast Cancer: New Targets, New Therapeutic Options. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2016. PMID: 27249746
Tempero M. Bringing Biosimilars to the Clinic: What's the Fuss? Journal of the National Comprehensive Cancer Network : JNCCN. 2016. PMID: 26733549
Tempero M. Pancreatic Adenocarcinoma: The Emperor of All Cancer Maladies. Journal of oncology practice. 2016. PMID: 26759462
Timothy Ferng, Catherine Choy Smith. Resistance to FLT3 Inhibitors. Resistance to Tyrosine Kinase Inhibitors. 2016. PMID:
Melisko ME, Gradishar WJ, Moy B. Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2016. PMID: 27249727
Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA. Prostate Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016. PMID: 26733552
Logan AC, Miklos DB.. Hematopoietic cell transplantation for chronic lymphocytic leukemia, in: Appelbaum FR, Forman SJ, Negrin RS, Antin JH (Eds). Thomas' Hematopoietic Cell Transplantation, 5th Ed, John Wiley & Sons, Ltd., Chichester, UK Hematopoietic cell transplantation for chronic lymphocytic leukemia, in: Appelbaum FR, Forman SJ, Negrin RS, Antin JH (Eds). Thomas' Hematopoietic Cell Transplantation, 5th Ed, John Wiley & Sons, Ltd., Chichester, UK.. 2015. PMID:
Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI, Ruffell B, Gorjestani S, Liudahl SM, Truitt M, Olson P, Kim G, Hanahan D, Tempero MA, Sheppard B, Irving B, Chang BY, Varner JA, Coussens LM. Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer. Cancer discovery. 2015. PMID: 26715645
Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, Allore H, Somerfield MR, Targia V, Extermann M, Cohen HJ, Hurria A, Holmes H. Comorbidity in older adults with cancer. Journal of geriatric oncology. 2015. PMID: 26725537
Carnevale J, Ko AH. MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer. Future oncology (London, England). 2015. PMID: 26685802
Barba P, Burns LJ, Litzow MR, Juckett MB, Komanduri KV, Lee SJ, Devlin SM, Costa LJ, Khan S, King A, Klein A, Krishnan A, Malone A, Mir M, Moravec C, Selby G, Roy V, Cochran M, Stricherz MK, Westmoreland MD, Perales MA, Wood WA. Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015. PMID: 26718665
Vijayaraghavan M, Hurst S, Pierce JP. Implementing Tobacco Control Programs in Homeless Shelters: A Mixed-Methods Study. Health promotion practice. 2015. PMID: 26678988